Ufuk Yılmaz

1.0k total citations
37 papers, 299 citations indexed

About

Ufuk Yılmaz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Ufuk Yılmaz has authored 37 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Ufuk Yılmaz's work include Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Neuroendocrine Tumor Research Advances (7 papers). Ufuk Yılmaz is often cited by papers focused on Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Neuroendocrine Tumor Research Advances (7 papers). Ufuk Yılmaz collaborates with scholars based in Türkiye, Kuwait and Norway. Ufuk Yılmaz's co-authors include Gülru Polat, Özgür Batum, Canan Kabaca, Cenk Kıraklı, Fahrettin Talay, Ateş Karateke, Ayşe Gürbüz, Zeynep Zeren Uçar, Ceyda Anar and Hüseyin Halilçolar and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Journal of Thoracic Oncology.

In The Last Decade

Ufuk Yılmaz

33 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ufuk Yılmaz Türkiye 10 176 95 69 37 29 37 299
Eyüp Avcı Türkiye 11 47 0.3× 61 0.6× 61 0.9× 23 0.6× 13 0.4× 34 289
N. J. R. GEORGE United Kingdom 11 200 1.1× 75 0.8× 55 0.8× 34 0.9× 98 3.4× 28 410
Muhammed Oylumlu Türkiye 12 67 0.4× 125 1.3× 65 0.9× 26 0.7× 26 0.9× 35 325
Güldem Kılcıler Türkiye 10 80 0.5× 45 0.5× 75 1.1× 25 0.7× 38 1.3× 24 334
Bénédicte Mastroïanni France 11 212 1.2× 108 1.1× 42 0.6× 13 0.4× 9 0.3× 25 306
Berna Akıncı Özyürek Türkiye 9 162 0.9× 148 1.6× 61 0.9× 15 0.4× 5 0.2× 42 347
Emmanuelle Boutmy Germany 9 107 0.6× 63 0.7× 19 0.3× 5 0.1× 35 1.2× 40 301
Yohei Taniguchi Japan 11 217 1.2× 63 0.7× 45 0.7× 47 1.3× 3 0.1× 53 387
Pierluigi Russo Italy 10 88 0.5× 40 0.4× 126 1.8× 19 0.5× 13 0.4× 51 358
Lise Ingemann Jensen Denmark 10 124 0.7× 77 0.8× 128 1.9× 48 1.3× 16 0.6× 22 377

Countries citing papers authored by Ufuk Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Ufuk Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ufuk Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ufuk Yılmaz more than expected).

Fields of papers citing papers by Ufuk Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ufuk Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ufuk Yılmaz. The network helps show where Ufuk Yılmaz may publish in the future.

Co-authorship network of co-authors of Ufuk Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Ufuk Yılmaz. A scholar is included among the top collaborators of Ufuk Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ufuk Yılmaz. Ufuk Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batum, Özgür, et al.. (2020). Metabolic activity of primary tumour on PET/CT has a relationship with survival in stages I‐III small‐cell lung carcinoma. The Clinical Respiratory Journal. 14(8). 695–702. 5 indexed citations
2.
Erbaycu, Ahmet Emin, et al.. (2020). Effect of Rebound Thymic Hyperplasia on Survival in Chemotherapy-Treated Lung Cancer. Turkish Thoracic Journal. 21(5). 303–307. 2 indexed citations
3.
Yılmaz, Ufuk, et al.. (2020). Lung cancer and COVID-19. SHILAP Revista de lepidopterología. 22(4). 70–70. 3 indexed citations
4.
Batum, Özgür, et al.. (2019). A Case of Rapidly Progressing and Fatal Endobronchial Aspergilloma Mimicking Lung Carcinoma. Turkish Thoracic Journal. 20(-1). 386–386.
5.
6.
Batum, Özgür, et al.. (2018). Use of adjuvant chemotherapy for nonsmall cell lung cancer: Is advanced age a prognostic factor?. Indian Journal of Cancer. 55(3). 282–282. 3 indexed citations
7.
Yılmaz, Ufuk, et al.. (2018). Valor pronóstico del SUV máx del tumor primario pretratamiento con PET/TC con 18 F-FDG en pacientes con cáncer de pulmón no microcítico en estadio iii. Revista Española de Medicina Nuclear e Imagen Molecular. 37(4). 218–222. 4 indexed citations
8.
Batum, Özgür, et al.. (2018). A new perspective for pulmonary thromboembolism radiology: ‘Pulmonary vein sign’. The Clinical Respiratory Journal. 12(12). 2653–2658. 2 indexed citations
9.
Yılmaz, Ufuk, et al.. (2017). Frequency of Silent Brain Metastasis Before Prophylactic Cranial Irradiation in Small Cell Lung Cancer. Turkish Thoracic Journal. 18(1). 11–13. 4 indexed citations
10.
11.
Yılmaz, Ufuk, et al.. (2015). Chemoradiotherapy-Associated Myelosuppression: A Retrospective Analysis of Risk Factors for Patients with Non-Small Cell Lung Cancer. Eurasian Journal of Pulmonology. 17(1). 49–53. 1 indexed citations
12.
Özçelik, Cemal, et al.. (2014). A Rare Form of Mesothelioma: Malignant Pleural Deciduoid Mesothelioma. Eurasian Journal of Pulmonology. 16(1). 44–46. 1 indexed citations
13.
Kıraklı, Cenk, et al.. (2014). Can Non-Thyroid Illness Syndrome Predict Mortality in Lung Cancer Patients? A Prospective Cohort Study. Hormones and Cancer. 5(4). 240–246. 37 indexed citations
14.
Yılmaz, Ufuk, Gülru Polat, Ceyda Anar, & Hüseyin Halilçolar. (2011). Carboplatin plus etoposide for extensive stage small-cell lung cancer: An experience with AUC 6 doses of carboplatin. Indian Journal of Cancer. 48(4). 454–454. 7 indexed citations
15.
Anar, Ceyda, et al.. (2010). Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease.. PubMed. 33(2). 117–27. 17 indexed citations
16.
Yılmaz, Ufuk, et al.. (2009). A Pericardiophrenic Vein Varix Mimicking a Pulmonary Mass. Journal of Thoracic Oncology. 4(7). 889–890. 1 indexed citations
17.
Yılmaz, Ufuk, et al.. (2009). Nodular lymphoid hyperplasia of the lung: the role of positron emission tomography in diagnosis.. PubMed. 57(4). 417–21. 6 indexed citations
18.
Leyvraz, Serge, S. Pampallona, Giovanni Martinelli, et al.. (2008). A Threefold Dose Intensity Treatment With Ifosfamide, Carboplatin, and Etoposide for Patients With Small Cell Lung Cancer: A Randomized Trial. JNCI Journal of the National Cancer Institute. 100(8). 533–541. 30 indexed citations
19.
Gürbüz, Ayşe, Ateş Karateke, Ufuk Yılmaz, & Canan Kabaca. (2006). The role of perinatal and intrapartum risk factors in the etiologyof cerebral palsy in term deliveries in a Turkish population. The Journal of Maternal-Fetal & Neonatal Medicine. 19(3). 147–155. 27 indexed citations
20.
Yılmaz, Ufuk, et al.. (1998). Computed tomographic findings of environmental asbestos‐related malignant pleural mesothelioma. Respirology. 3(1). 33–38. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eyüp Avcı Breakdown of academic impact, for papers by N. J. R. GEORGE Breakdown of academic impact, for papers by Muhammed Oylumlu Breakdown of academic impact, for papers by Güldem Kılcıler Breakdown of academic impact, for papers by Bénédicte Mastroïanni Breakdown of academic impact, for papers by Berna Akıncı Özyürek Breakdown of academic impact, for papers by Emmanuelle Boutmy Breakdown of academic impact, for papers by Yohei Taniguchi Breakdown of academic impact, for papers by Pierluigi Russo Breakdown of academic impact, for papers by Lise Ingemann Jensen
Rankless by CCL
2026